Search results
Results from the WOW.Com Content Network
City car (A-segment) hatchback. Marketed as the Cultus in Pakistan. Ignis: 2000 2016 Global Crossover-styled city car (A-segment). S-Presso: 2019 2019 India and other emerging markets Crossover-styled entry-level city car manufactured by Maruti Suzuki in India. Swift: 1984 (nameplate introduction) 2004 2023 Global Subcompact (B-segment ...
The Indian model (2010) called Wagon R 1.0, is powered by the more efficient three-cylinder 998 cc K10B engine, which can also be found in the Maruti Suzuki A-Star, Maruti Suzuki Estilo, and the Maruti Suzuki Alto K10. The engine delivers 68 PS (50 kW; 67 hp) at 6,200 rpm, and 90 N⋅m (66 lb⋅ft) at 3 500 rpm.
The Suzuki Wagon R (Japanese: スズキ・ワゴンR, Suzuki Wagon'āru) is a kei car manufactured and marketed by Suzuki since 1993. The R in the name stands for Revolution and Relaxation. [ 1 ] The Wagon R uses a "tall wagon" configuration to maximize cabin space within kei car dimensional restrictions.
Maruti Suzuki launched the car in India on 23 February 2022 with the same four trim levels as previous generation; Sigma, Delta, Zeta and Alpha. [80] It is also retained the same 1.2-litre K12N Dualjet petrol engine and 5-speed manual transmission, while the CVT option was replaced with the cheaper AMT unit.
A Euro III emission-compliant version of the car was released in 2005 to meet Indian emissions regulations. An LPG version of the vehicle was also released in 2008. As of September 2009, the company has yet to reach a decision regarding the manufacture of a Euro IV-compliant version of the vehicle because it would increase the retail price ...
We’re ready for a whole new set of explorations in 2025 with picks for 25 top places to visit. Take cues from the worst-behaved travelers of 2024 for what not to do in the year ahead.
Main page; Contents; Current events; Random article; About Wikipedia; Contact us
Eduardo Cuevas, USA TODAY. December 17, 2024 at 6:40 PM. A discredited study that set off a flurry of interest in using an antimalarial drug to treat COVID-19 has now been formally withdrawn.